Zobrazeno 1 - 10
of 226
pro vyhledávání: '"MG Belvisi"'
Publikováno v:
The European respiratory journal. 3(3)
The contribution of neutrophils to the action of endotoxin on plasma exudation in the airways of anaesthetized guinea-pigs was quantified by measuring the extravasation of Evans blue dye. Endotoxin (Salmonella enteritidis) caused a dose-dependent inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d856c5253c3cd75e3348d244f96699fb
https://pubmed.ncbi.nlm.nih.gov/2187707
https://pubmed.ncbi.nlm.nih.gov/2187707
Autor:
Silverberg JI; The George Washington University School of Medicine and Health Sciences, Washington, DC, USA., Mustapa MN; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Reid F; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Lei A; Patient Safety Biopharma, AstraZeneca, Barcelona, Spain., Smith R; Respiratory & Immunology Biometrics and Statistical Innovation, Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Moate R; Respiratory & Immunology Biometrics and Statistical Innovation, Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Kelly A; Precision Medicine Discovery & Development, Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Chen R; Precision Medicine Discovery & Development, Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Gavala M; Precision Medicine Discovery & Development, Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Jimenez E; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Barcelona, Spain., Belvisi MG; Research and Early Development, Respiratory and Immunology, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Sadiq MW; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Kell C; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Pandya HC; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Nov 13. Date of Electronic Publication: 2024 Nov 13.
Autor:
Long MB; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom., Gilmour A; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom., Kehl M; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Tabor DE; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Keller AE; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Warrener P; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Gopalakrishnan V; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Rosengren S; Translational Science and Experimental Medicine, Respiratory & Immunology, Respiratory and Immunology, and., Crichton ML; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom., McIntosh E; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom., Giam YH; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom., Keir HR; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom., Brailsford W; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and., Hughes R; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Belvisi MG; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and., Sellman BR; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., DiGiandomenico A; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Chalmers JD; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 Jul 01; Vol. 210 (1), pp. 35-46.
Autor:
Pinkerton JW; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK., Preite S; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden., Piras A; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden., Zervas D; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK., Markou T; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK., Freeman MS; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK., Hofving T; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden., Ivarsson E; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden., Bonvini SJ; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK., Brailsford W; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden., Yrlid L; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden., Belvisi MG; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK., Birrell MA; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden. mark.birrell@astrazeneca.com.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK. mark.birrell@astrazeneca.com.
Publikováno v:
Respiratory research [Respir Res] 2024 Apr 23; Vol. 25 (1), pp. 175. Date of Electronic Publication: 2024 Apr 23.
Autor:
van Laar JM; Division of Internal Medicine and Dermatology, Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Lei A; Patient Safety BioPharmaceuticals, Chief Medical Office, R&D, AstraZeneca, Barcelona, Spain., Safy-Khan M; Division of Internal Medicine and Dermatology, Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Almquist J; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Belfield G; Translational Genomics, Discovery Biology SE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Edman K; Mechanistic and Structural Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Öberg L; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Angermann BR; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Dillmann I; Translational Genomics, Discovery Biology SE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Berntsson P; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Etal D; Translational Genomics, Discovery Biology SE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Dainty I; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Astbury C; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Belvisi MG; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK., Nemes S; Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Prothon S; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Samuelsson S; Clinical Development, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Svanberg P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Keen C; Clinical Development, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2023 Dec; Vol. 16 (12), pp. 2494-2506. Date of Electronic Publication: 2023 Oct 23.
Autor:
Saunders P; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Oxford University Hospitals NHS Trust, Oxford, United Kingdom., Wu Z; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Fahy WA; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Stewart ID; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Saini G; Centre for Respiratory Research, NIHR Biomedical Research Centre, Translational Medical Sciences, University of Nottingham, Nottingham, United Kingdom., Smith DJF; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Braybrooke R; Centre for Respiratory Research, NIHR Biomedical Research Centre, Translational Medical Sciences, University of Nottingham, Nottingham, United Kingdom., Stock C; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Renzoni EA; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Johnson SR; Centre for Respiratory Research, NIHR Biomedical Research Centre, Translational Medical Sciences, University of Nottingham, Nottingham, United Kingdom., Jenkins RG; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Belvisi MG; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., Smith JA; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Division of Infection, Immunity and Respiratory Medicine, The University of Manchester, Manchester, United Kingdom., Maher TM; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Hastings Centre for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Molyneaux PL; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Publikováno v:
Annals of the American Thoracic Society [Ann Am Thorac Soc] 2023 Sep; Vol. 20 (9), pp. 1267-1273.
Autor:
Nilsson M; Medicinal Chemistry, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Rhedin M; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Hendrickx R; DMPK, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Berglund S; Medicinal Chemistry, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Piras A; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Blomgran P; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Cavallin A; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Collins M; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Dahl G; Discovery Science, R&D, AstraZeneca, Gothenburg, Sweden., Dekkak B; Respiratory Pharmacology Group, Division of Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK., Ericsson T; DMPK, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Hagberg N; Rheumatology and Science for Life Laboratories, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Holmberg AA; DMPK, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Leffler A; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Lundqvist AJ; DMPK, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Markou T; Respiratory Pharmacology Group, Division of Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK.; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Pinkerton J; Respiratory Pharmacology Group, Division of Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK.; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Rönnblom L; Rheumatology and Science for Life Laboratories, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Siu S; Rigel Pharmaceuticals, South San Francisco, CA, USA., Taylor V; Rigel Pharmaceuticals, South San Francisco, CA, USA., Wennberg T; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Zervas D; Respiratory Pharmacology Group, Division of Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK.; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Laurence ADJ; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Mitra S; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Belvisi MG; Respiratory Pharmacology Group, Division of Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK.; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Birrell M; Respiratory Pharmacology Group, Division of Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK.; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Borde A; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
Drug design, development and therapy [Drug Des Devel Ther] 2022 Aug 31; Vol. 16, pp. 2901-2917. Date of Electronic Publication: 2022 Aug 31 (Print Publication: 2022).
Autor:
Hristova VA; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; These authors contributed equally., Watson A; Faculty of Medicine, University of Southampton, Southampton, UK.; School of Clinical Medicine, University of Cambridge, Cambridge, UK.; These authors contributed equally., Chaerkady R; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Glover MS; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Ackland J; Faculty of Medicine, University of Southampton, Southampton, UK., Angerman B; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Belfield G; Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Belvisi MG; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; NHLI, Imperial College, London, UK., Burke H; Faculty of Medicine, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital, Southampton, UK., Cellura D; Faculty of Medicine, University of Southampton, Southampton, UK., Clark HW; Neonatology, Faculty of Population Health Sciences, EGA Institute for Women's Health, University College London, London, UK.; NIHR University College London Hospital Biomedical Research, University College London Hospital, London, UK., Etal D; Translational Genomics, Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Freeman A; Faculty of Medicine, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital, Southampton, UK., Heinson AI; Faculty of Medicine, University of Southampton, Southampton, UK., Hess S; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Hühn M; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Hall E; Faculty of Medicine, University of Southampton, Southampton, UK., Mackay A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; NHLI, Imperial College, London, UK., Madsen J; Faculty of Medicine, University of Southampton, Southampton, UK., McCrae C; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA., Muthas D; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Novick S; Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Ostridge K; Faculty of Medicine, University of Southampton, Southampton, UK.; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Öberg L; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Postle AD; Faculty of Medicine, University of Southampton, Southampton, UK., Spalluto CM; Faculty of Medicine, University of Southampton, Southampton, UK., Vaarala O; Faculty of Medicine, University of Helsinki, Helsinki, Finland., Wang J; Dynamic Omics, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Staples KJ; Faculty of Medicine, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital, Southampton, UK., Wilkinson TMA; Faculty of Medicine, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital, Southampton, UK.
Publikováno v:
ERJ open research [ERJ Open Res] 2022 May 15; Vol. 9 (3). Date of Electronic Publication: 2022 May 15 (Print Publication: 2023).
Autor:
Yoon M; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada., Ryu MH; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada., Huff RD; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada., Belvisi MG; Research and Early Development, Respiratory Pharmacology Group, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK., Smith J; Division of Infection, Immunity, and Respiratory Medicine, University of Manchester, 16 Manchester Academic Health Sciences Centre, and Manchester University NHS Foundation 17 Trust, Manchester, UK., Carlsten C; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada. carlsten@mail.ubc.ca.; The Lung Center, Vancouver General Hospital-Gordon and Leslie Diamond Health Care Centre, 2775 Laurel St. 7th Floor, Vancouver, BC, V5Z 1M9, Canada. carlsten@mail.ubc.ca.
Publikováno v:
Respiratory research [Respir Res] 2022 May 04; Vol. 23 (1), pp. 113. Date of Electronic Publication: 2022 May 04.
Autor:
Singh D; Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester, UK dsingh@meu.org.uk.; Division of Infection, Immunity and Respiratory Medicine, University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK., Beier J; insaf Respiratory Research Institute Wiesbaden, Wiesbaden, Germany., Astbury C; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Belvisi MG; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology Group, Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK., Da Silva CA; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Jauhiainen A; BioPharma Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Jimenez E; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Barcelona, Spain., Lei A; Patient Safety BioPharma, Chief Medical Office, R&D, AstraZeneca, Barcelona, Spain., Necander S; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Smith JA; Division of Infection, Immunity and Respiratory Medicine, University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK., Wählby Hamrén U; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Xin W; BioPharma Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Psallidas I; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Publikováno v:
The European respiratory journal [Eur Respir J] 2022 Apr 07; Vol. 59 (4). Date of Electronic Publication: 2022 Apr 07 (Print Publication: 2022).